• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau蛋白多位点磷酸化的数学模型。

A mathematical model of multisite phosphorylation of tau protein.

作者信息

Stepanov Alexander, Karelina Tatiana, Markevich Nikolai, Demin Oleg, Nicholas Timothy

机构信息

InSysBio, Moscow, Russia.

Pfizer Global R&D, Groton, Connecticut, United States of America.

出版信息

PLoS One. 2018 Feb 6;13(2):e0192519. doi: 10.1371/journal.pone.0192519. eCollection 2018.

DOI:10.1371/journal.pone.0192519
PMID:29408874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5800643/
Abstract

Abnormal tau metabolism followed by formation of tau deposits causes a number of neurodegenerative diseases called tauopathies including Alzheimer's disease. Hyperphosphorylation of tau protein precedes tau aggregation and is a topic of interest for the development of pharmacological interventions to prevent pathology progression at early stages. The development of a mathematical model of multisite phosphorylation of tau would be helpful for searching for the targets of pharmacological interventions and candidates for biomarkers of pathology progression. In the present study, we for the first time developed a model of multisite phosphorylation of tau protein and elucidated the relative contribution of kinases to phosphorylation of distinct sites. The model describes phosphorylation of tau or PKA-prephosphorylated tau by GSK3β and CDK5 and dephosphorylation by PP2A, accurately reproducing the data for short-term kinetics of tau (de)phosphorylation. Our results suggest that kinase inhibition may more specifically prevent tau hyperphosphorylation, e.g., on PHF sites, which are key biomarkers of pathological changes in Alzheimer's disease. The main features of our model are partial phosphorylation of tau residues and merging of random and sequential mechanisms of multisite phosphorylation within the framework of the probability-based approach assuming independent phosphorylation events.

摘要

异常的tau蛋白代谢随后形成tau沉积物会导致多种被称为tau蛋白病的神经退行性疾病,包括阿尔茨海默病。tau蛋白的过度磷酸化先于tau蛋白聚集,并且是开发用于预防早期病理进展的药理学干预措施的一个研究热点。开发tau蛋白多位点磷酸化的数学模型将有助于寻找药理学干预的靶点以及病理进展生物标志物的候选物。在本研究中,我们首次开发了tau蛋白多位点磷酸化模型,并阐明了激酶对不同位点磷酸化的相对贡献。该模型描述了GSK3β和CDK5对tau蛋白或PKA预磷酸化的tau蛋白的磷酸化以及PP2A的去磷酸化,准确地再现了tau蛋白(去)磷酸化的短期动力学数据。我们的结果表明,激酶抑制可能更特异性地预防tau蛋白过度磷酸化,例如在PHF位点上,这些位点是阿尔茨海默病病理变化的关键生物标志物。我们模型的主要特征是tau蛋白残基的部分磷酸化以及在基于概率的方法框架内假设独立磷酸化事件的多位点磷酸化的随机和顺序机制的合并。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/027d7fa17973/pone.0192519.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/ffa4eaac51b4/pone.0192519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/61699ef352a5/pone.0192519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/d69f69ddba8d/pone.0192519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/ad5c17cd3bd4/pone.0192519.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/dfa19cc6605e/pone.0192519.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/6b2306f1a47a/pone.0192519.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/17a8c2eefa66/pone.0192519.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/8b978715809b/pone.0192519.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/027d7fa17973/pone.0192519.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/ffa4eaac51b4/pone.0192519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/61699ef352a5/pone.0192519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/d69f69ddba8d/pone.0192519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/ad5c17cd3bd4/pone.0192519.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/dfa19cc6605e/pone.0192519.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/6b2306f1a47a/pone.0192519.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/17a8c2eefa66/pone.0192519.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/8b978715809b/pone.0192519.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d4/5800643/027d7fa17973/pone.0192519.g009.jpg

相似文献

1
A mathematical model of multisite phosphorylation of tau protein.tau蛋白多位点磷酸化的数学模型。
PLoS One. 2018 Feb 6;13(2):e0192519. doi: 10.1371/journal.pone.0192519. eCollection 2018.
2
Tau pathology in Alzheimer disease and other tauopathies.阿尔茨海默病及其他tau蛋白病中的tau蛋白病变
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210. doi: 10.1016/j.bbadis.2004.09.008.
3
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.参与阿尔茨海默病神经纤维变性的激酶、磷酸酶及tau位点。
Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x.
4
Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.阿尔茨海默病中的 Tau 蛋白磷酸酶:PP2A 的主要作用。
Ageing Res Rev. 2013 Jan;12(1):39-49. doi: 10.1016/j.arr.2012.06.008. Epub 2012 Jul 6.
5
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.Tau 在各种 Tau 病中的作用、治疗方法以及纳米技术在神经退行性疾病中的新作用。
Mol Neurobiol. 2023 Mar;60(3):1690-1720. doi: 10.1007/s12035-022-03164-z. Epub 2022 Dec 23.
6
Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.锌通过 Src 依赖性蛋白磷酸酶 2A(酪氨酸 307 位)磷酸化诱导蛋白磷酸酶 2A 失活和 tau 过度磷酸化。
Neurobiol Aging. 2013 Mar;34(3):745-56. doi: 10.1016/j.neurobiolaging.2012.07.003. Epub 2012 Aug 11.
7
Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'.蛋白磷酸酶 2A 与 tau:一场精心编排的“双人舞”。
FEBS Lett. 2018 Apr;592(7):1079-1095. doi: 10.1002/1873-3468.12907. Epub 2017 Nov 19.
8
HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.HS3ST2的表达对于阿尔茨海默病相关tau蛋白病变中tau蛋白的异常磷酸化至关重要。
Brain. 2015 May;138(Pt 5):1339-54. doi: 10.1093/brain/awv056. Epub 2015 Apr 4.
9
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白,可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
10
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.硒酸钠特异性激活 PP2A 磷酸酶,使 tau 去磷酸化,并逆转阿尔茨海默病模型中的记忆缺陷。
J Clin Neurosci. 2010 Aug;17(8):1025-33. doi: 10.1016/j.jocn.2010.04.020. Epub 2010 May 26.

引用本文的文献

1
Mathematical modelling of Alzheimer's disease biomarkers: Targeting Amyloid beta, Tau protein, Apolipoprotein E and Apoptotic pathways.阿尔茨海默病生物标志物的数学建模:针对淀粉样β蛋白、 Tau蛋白、载脂蛋白E和凋亡途径
Am J Transl Res. 2024 Jul 15;16(7):2777-2792. doi: 10.62347/UJQF5204. eCollection 2024.
2
Targeted Quantification of Protein Phosphorylation and Its Contributions towards Mathematical Modeling of Signaling Pathways.蛋白质磷酸化的靶向定量及其对信号通路数学建模的贡献。
Molecules. 2023 Jan 23;28(3):1143. doi: 10.3390/molecules28031143.
3
Network regulation meets substrate modification chemistry.

本文引用的文献

1
Alzheimer's drug-development pipeline: 2016.2016年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2016 Aug 17;2(4):222-232. doi: 10.1016/j.trci.2016.07.001. eCollection 2016 Nov.
2
Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.利用ADNI-2数据库比较脑脊液标志物和半定量淀粉样蛋白PET在阿尔茨海默病诊断及认知障碍预后中的应用
Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.
3
C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A.
网络调控与底物修饰化学。
J R Soc Interface. 2023 Feb;20(199):20220510. doi: 10.1098/rsif.2022.0510. Epub 2023 Feb 1.
4
Hallmarks of neurodegenerative disease: A systems pharmacology perspective.神经退行性疾病的标志:系统药理学视角。
CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1399-1429. doi: 10.1002/psp4.12852. Epub 2022 Aug 17.
5
Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation.阿尔茨海默病:消融单一主站点可消除 Tau 过度磷酸化。
Sci Adv. 2022 Jul 8;8(27):eabl8809. doi: 10.1126/sciadv.abl8809. Epub 2022 Jul 6.
6
Symmetry breaking meets multisite modification.对称破缺与多位点修饰相遇。
Elife. 2021 May 21;10:e65358. doi: 10.7554/eLife.65358.
7
The small molecule DIPQUO promotes osteogenic differentiation via inhibition of glycogen synthase kinase 3-beta signaling.小分子 DIPQUO 通过抑制糖原合成激酶 3-β信号通路促进成骨细胞分化。
J Biol Chem. 2021 Jan-Jun;296:100696. doi: 10.1016/j.jbc.2021.100696. Epub 2021 Apr 22.
8
Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform.单克隆抗体疗法与其他治疗方法联合使用可提高疗效:使用综合阿尔茨海默病平台进行的预测。
CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):543-550. doi: 10.1002/psp4.12628. Epub 2021 May 2.
9
Exploring cyclic networks of multisite modification reveals origins of information processing characteristics.探索多部位修饰的循环网络揭示了信息处理特征的起源。
Sci Rep. 2020 Oct 6;10(1):16542. doi: 10.1038/s41598-020-73045-9.
10
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.定量系统神经药理学在神经科学药物研发中的应用:现状、机遇与挑战。
CPT Pharmacometrics Syst Pharmacol. 2020 Jan;9(1):5-20. doi: 10.1002/psp4.12478. Epub 2019 Nov 24.
糖原合成酶激酶3β(GSK-3β)的C末端截短增强了其被蛋白磷酸酶2A(PP2A)的去磷酸化作用。
FEBS Lett. 2017 Apr;591(7):1053-1063. doi: 10.1002/1873-3468.12617. Epub 2017 Mar 23.
4
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.tau 蛋白特定位点磷酸化抑制阿尔茨海默病小鼠的淀粉样β毒性。
Science. 2016 Nov 18;354(6314):904-908. doi: 10.1126/science.aah6205.
5
Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.治疗tau 病的治疗策略:希望与挑战。
Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006.
6
Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model.在tau蛋白病小鼠模型中,降低Nuak1可减少tau蛋白并逆转表型。
Neuron. 2016 Oct 19;92(2):407-418. doi: 10.1016/j.neuron.2016.09.022. Epub 2016 Oct 6.
7
GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.糖原合酶激酶3β(GSK-3β)以不依赖亮氨酸309甲基化的方式被蛋白磷酸酶2A(PP2A)去磷酸化。
J Alzheimers Dis. 2016;49(2):365-75. doi: 10.3233/JAD-150497.
8
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.脑脊液磷酸化tau蛋白181位点(P-Tau181P):改善痴呆鉴别诊断的生物标志物
Front Neurol. 2015 Jun 17;6:138. doi: 10.3389/fneur.2015.00138. eCollection 2015.
9
Comparison of asymptotic confidence sets for regression in small samples.小样本回归中渐近置信集的比较
J Biopharm Stat. 2016;26(4):742-57. doi: 10.1080/10543406.2015.1052818. Epub 2015 Jun 22.
10
Mixed mechanisms of multi-site phosphorylation.多位点磷酸化的混合机制
J R Soc Interface. 2015 Jun 6;12(107). doi: 10.1098/rsif.2014.1405.